Jnana Therapeutics Funding: $50M Raised, Series A (2017)
Jnana Therapeutics is a Biotech company based in Boston. It has raised $50M in total funding. Latest round: Series A.
Jnana Therapeutics funding overview
Jnana Therapeutics is a Biotech company based in Boston. Jnana Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2017. The round record for Jnana Therapeutics runs through 2017; nothing later has been disclosed. Investors on record include Polaris Partners, Avalon Ventures, Versant Ventures, AbbVie Ventures, Pfizer R&D Innovate. 5 distinct backers are named across the disclosed rounds.
Jnana Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Jnana Therapeutics?
Polaris Partners, Avalon Ventures, Versant Ventures, AbbVie Ventures, Pfizer R&D Innovate are named among the investors backing Jnana Therapeutics.
What was the latest Jnana Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2017.
Where is Jnana Therapeutics based?
Jnana Therapeutics is based in Boston.
What sector does Jnana Therapeutics operate in?
Jnana Therapeutics is tracked under Biotech from Boston, with $50M in disclosed funding.
When did Jnana Therapeutics last raise?
The last disclosed Jnana Therapeutics round closed in December 2017 at Series A.
Jnana Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Boston below to benchmark round size and investor mix.
